New study aims to sharpen vision tests for the blind

NCT ID NCT07502664

Recruiting now Knowledge-focused Sponsor: Ray Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study enrolls 25 people with severe retinal diseases like retinitis pigmentosa and Stargardt disease to test new ways of measuring visual function. Researchers will evaluate how well participants can perform various vision tests, such as navigating obstacles or detecting light. The goal is to create more reliable endpoints for future clinical trials, not to test a new treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better, more reliable tests for measuring vision in people with severe retinal diseases, helping future treatments prove their effectiveness.
What could go wrong: This is a small, early-stage study focused on measurement methods, not a treatment. It may not result in any direct benefit to participants or change clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY FROM AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GEOGRAPHIC ATROPHY FROM AGE-RELATED MACULAR DEGENERATION RETINAL DYSTROPHIES RETINITIS PIGMENTOSA STARGARDT DISEASE STARGARDT MACULAR DYSTROPHY X-LINKED RETINOSCHISIS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Vision Research and Assessment Institute
RECRUITING

Irvine, California, 92614, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.